NSE ZYDUSWELL · BSE 531335 · Food Processing · NIFTY 500

Zydus Wellness Share Price

Market closed · updated 25 Sep, 4:52 PM IST

₹520.10 ▼ −₹10.99 · 2.07% NSE · as of 24 Sep 2026, 9:57 AM · BSE ₹519.00

Today's range

₹519.00Low₹530.85High

52-week range

₹357.55Low · 2 Mar 2026₹610.95High · 20 Jul 2026

Zydus Wellness Overview

Where the price stands, how it has moved and how it sits against its averages.

Zydus Wellness shares last traded at ₹520.10 on the NSE, down 2.07% on the day. That is 14.9% below the 52-week high of ₹610.95 and 45.5% above the 52-week low of ₹357.55. The stock trades at 97.99× earnings, above the sector average of 22.10. Its market value is ₹16,491 Cr.

Price returns

1 Day▼ −2.07%

5 Days▼ −3.77%

This month▲ +0.11%

3 Months▲ +1.04%

6 Months▲ +15.95%

This year▲ +16.81%

1 Year▲ +12.07%

Against the market: 1 Month ▲ +3.89% · 3 Months ▲ +3.96% · 6 Months ▲ +16.64% · This year ▲ +33.03% · 1 Year ▲ +22.97%

Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next update from Mon 28 Sep, 9:15 AM.

Moving averages — price is above 1 of 6

10-day average₹545.18 ▼ price 4.6% below
50-day average₹541.88 ▼ price 4.0% below
20-day average₹539.36 ▼ price 3.6% below
5-day average₹534.24 ▼ price 2.6% below
100-day average₹532.07 ▼ price 2.2% below
Today's price₹520.10
300-day average₹482.36 ▲ price 7.8% above

Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.

Zydus Wellness Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore

3,961

Net profit₹ crore · losses below zero

347

197

Year by year

Fiscal year	Revenue	Growth	Net profit	Net margin	EPS	Dividend
FY 2026	₹3,961 Cr	▲ +46.2%	₹197 Cr	5.0%	₹6.20	₹1.20
FY 2025	₹2,709 Cr	▲ +16.4%	₹347 Cr	12.8%	₹10.90	₹1.20
FY 2024	₹2,328 Cr	▲ +3.2%	₹267 Cr	11.5%	₹8.39	₹1.00
FY 2023	₹2,255 Cr	▲ +12.2%	₹310 Cr	13.8%	₹9.76	₹1.00
FY 2022	₹2,009 Cr	▲ +7.6%	₹309 Cr	15.4%	₹9.71	₹1.00
FY 2021	₹1,867 Cr	▲ +5.7%	₹119 Cr	6.4%	₹3.91	₹1.00
FY 2020	₹1,767 Cr	—	₹142 Cr	8.0%	₹4.92	₹5.00

Revenue₹ crore

1,485

1,437

Net profit₹ crore · losses below zero

172

−53

119

Quarter by quarter

Quarter	Revenue	vs prev. qtr	Net profit	Net margin	EPS
Q1 FY27	₹1,437 Cr	▼ −3.2%	₹119 Cr	8.3%	₹3.74
Q4 FY26	₹1,485 Cr	▲ +53.9%	₹162 Cr	10.9%	₹5.04
Q3 FY26	₹965 Cr	▲ +48.3%	−₹40 Cr	−4.1%	−₹1.25
Q2 FY26	₹651 Cr	▼ −24.4%	−₹53 Cr	−8.1%	−₹1.66
Q1 FY26	₹861 Cr	▼ −5.7%	₹128 Cr	14.9%	₹4.02
Q4 FY25	₹913 Cr	▲ +97.7%	₹172 Cr	18.8%	₹5.37
Q3 FY25	₹462 Cr	▼ −6.3%	₹6 Cr	1.4%	₹0.20
Q2 FY25	₹493 Cr	—	₹21 Cr	4.2%	₹0.66

Balance sheet — FY26

Owes (liabilities)Shareholders' equity

43%

57%

Total assets₹10,308 Cr
Total liabilities₹4,482 Cr
Shareholders' equity₹5,826 Cr
Total debt₹3,203 Cr
Cash & investments₹115 Cr
Current ratio1.88×
Revenue growth, 5 yr16.24% a year
EPS growth, 5 yr9.66% a year
Operating margin (TTM)7.83%
Net margin (TTM)4.15%

Cash flow — FY26

Operating activities

▲ ₹254 Cr

Investing activities

▼ −₹2,910 Cr

Financing activities

▲ ₹2,698 Cr

Free cash flow

▲ ₹152 Cr

Net change in cash

▲ ₹44 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY20–FY26

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Total revenue	1,766.82	1,866.67	2,009.10	2,254.79	2,327.80	2,708.90	3,961.00
Cost of revenue	809.74	876.19	1,017.94	1,196.23	1,138.50	1,323.40	1,613.20
Gross profit	957.08	990.48	991.16	1,058.56	1,189.30	1,385.50	2,347.80
Operating expenses	1,516.33	1,679.60	1,687.09	1,952.34	2,061.20	2,357.20	3,646.10
Operating income	250.49	187.07	322.01	302.45	266.60	351.70	314.90
Depreciation	26.39	25.16	23.62	25.02	23.80	28.40	146.70
Profit before tax	121.27	112.21	306.02	290.86	260.10	358.80	230.50
Tax	−20.45	−6.52	−2.85	−19.51	−6.80	11.90	33.30
Net profit	141.72	118.73	308.87	310.37	266.90	346.90	197.20
EPS (₹)	4.92	3.91	9.71	9.76	8.39	10.90	6.20
Dividend per share (₹)	5.00	1.00	1.00	1.00	1.00	1.20	1.20

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Total assets	5,589.68	5,666.43	5,692.18	5,833.05	6,148.40	6,441.90	10,307.80
Current assets	775.79	846.89	813.70	907.82	1,214.30	1,104.20	1,366.70
Cash & short-term investments	192.03	252.11	196.27	107.67	316.00	109.20	114.90
Inventory	306.18	374.36	366.88	464.73	476.00	524.70	777.00
Property, plant & equipment	208.20	203.31	256.39	283.32	256.40	305.50	338.40
Total liabilities	2,129.02	1,098.64	848.15	710.40	790.90	770.30	4,481.80
Current liabilities	615.16	770.92	766.81	692.40	769.40	745.50	728.50
Total debt	1,519.83	550.40	387.34	297.21	328.70	188.30	3,202.80
Total equity	3,460.66	4,567.79	4,844.03	5,122.65	5,357.50	5,671.60	5,826.00

₹ crore	FY20	FY21	FY22	FY23	FY24	FY25	FY26
From operations	259.25	286.73	236.85	91.71	246.40	396.60	253.50
From investing	−17.12	−10.41	−58.93	−84.84	−19.30	−223.60	−2,909.90
From financing	−259.69	−216.43	−233.82	−138.49	−25.70	−186.30	2,698.40
Capital expenditure	−24.63	−19.66	−75.44	−44.96	−28.50	−66.30	−101.70
Dividends paid	−57.58	−0.19	−31.88	−31.89	−31.90	−31.80	−38.20
Net change in cash	−17.56	59.89	−55.90	−131.62	201.40	−13.30	43.90

What Analysts Say

7 analysts

Recommendations from 7 analysts who cover Zydus Wellness.

Buy average rating 1.86 on a 1–5 scale

Strong buyBuyHoldSellStrong sell

▲ 5 bullish (71.4%) · 2 hold (28.6%) · ▼ 0 bearish (0.0%)

Votes

Strong Buy

3 (43%)

Buy

2 (29%)

Hold

2 (29%)

Sell

0 (0%)

Strong Sell

0 (0%)

How the votes changed

Rating	3M ago	2M ago	1M ago	1W ago	Now	3-month change
Strong Buy	5	5	3	3	3	▼ −2
Buy	1	1	2	2	2	▲ +1
Hold	1	1	2	2	2	▲ +1
Sell	0	0	0	0	0	—
Strong Sell	0	0	0	0	0	—

Analyst ratings are opinions, not a guarantee of returns.

Zydus Wellness vs Peers

Side by side with other food processing companies. The small bars compare each column.

Company	Price	Change	Market cap	P/E	P/B	ROE (5 yr)	Net margin	Div. yield	Rating
Zydus Wellness	₹520.10	▼ −2.07%	₹16,491 Cr	97.99	2.90	5.46%	4.15%	0.23%	This stock
Nestle India	₹1,353.15	▼ −2.09%	₹2,60,930 Cr	80.40	53.37	—	15.11%	0.84%	Bearish
Britannia Industries	₹4,930.00	▼ −0.14%	₹1,18,748 Cr	51.47	25.53	57.16%	13.25%	1.67%	Bearish
Godrej Industries	₹1,098.10	▼ −0.76%	₹36,943 Cr	34.92	4.02	9.17%	10.85%	—	Moderately Bearish
Tata Consumer Products	₹985.80	▼ −1.02%	₹97,564 Cr	67.40	4.94	7.14%	8.07%	0.92%	Bearish
Patanjali Foods	₹405.45	▼ −0.89%	₹44,117 Cr	18.91	2.81	12.07%	4.50%	1.14%	Moderately Bullish

Rating = the data provider's overall technical view of each peer. Company names link to their own pages.

Shareholding Pattern

Who owns Zydus Wellness shares, quarter by quarter (latest on top).

PromoterFIIMFOther

Jun '26

69.6%

18.7%

Mar '26

Dec '25

Sep '25

Holder	Sep '25	Dec '25	Mar '26	Jun '26	Change
Promoter	69.63%	69.63%	69.63%	69.64%	▲ +0.01 pts
FII	3.43%	3.27%	3.17%	3.32%	▲ +0.15 pts
MF	18.15%	18.11%	18.43%	18.73%	▲ +0.30 pts
Other	8.79%	8.99%	8.77%	8.31%	▼ −0.46 pts

Zydus Wellness Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Zydus WellnessBenchmarkComfortable → stretched

Valuation Is the price reasonable?

P/E (TTM)Price ÷ yearly earnings per share

97.99

▲ 343% above the sector average of 22.10

P/E, 12-month rangeLow 30.92 · high 97.99

100%

Today's P/E sits 100% of the way from its low to its high

P/BPrice ÷ book value per share

2.90

P/SPrice ÷ sales per share

3.72

P/CFPrice ÷ cash flow per share

44.32

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods

63.14%

▲ above its 5-yr average of 52.58%

Operating marginKept after running costs

7.83%

▼ below its 5-yr average of 11.75%

Pre-tax marginKept before tax

5.45%

▼ below its 5-yr average of 10.91%

Net marginKept as profit

4.15%

▼ below its 5-yr average of 10.78%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money

3.43%

▼ below its 5-yr average of 5.46%

Return on assetsProfit on everything it owns

2.35%

▼ below its 5-yr average of 4.46%

Return on investmentProfit on long-term capital

2.58%

▼ below its 5-yr average of 5.04%

Growth Is the business getting bigger?

Revenue — last 12 months

+66.3%

▲ growing (off the scale)

Revenue — 3 yr, a year

+20.7%

▲ growing

Revenue — 5 yr, a year

+16.2%

▲ growing

EPS — last 12 months

−42.7%

▼ shrinking (off the scale)

EPS — 3 yr, a year

−14.0%

▼ shrinking

EPS — 5 yr, a year

+9.7%

▲ growing

Dividend — 3 yr, a year

+6.3%

▲ growing

Book value — 5 yr, a year

+5.0%

▲ growing

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money

0.55×

• Moderate

Current ratioShort-term assets for every ₹1 due within a year

1.88×

✓ Comfortable

Quick ratioLike the current ratio, without inventory

0.81×

• Adequate

Interest coverOperating profit ÷ interest to pay

4.32×

• Adequate

Payout ratioShare of profit paid as dividend

19.36%

• Keeps most

Per share What each share stands for

EPS (TTM)

₹5.87

Book value

₹183.09

Cash flow

₹11.95

Dividend

₹1.20

Revenue

₹142.18

The share price is 2.84× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 109 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year85.67

Current Dividend Yield - Common Stock Primary Issue, LTM0.23

Price to Book - most recent fiscal year2.90

P/E Basic excluding extraordinary items - TTM97.99

P/E including extraordinary items - TTM90.43

P/E excluding extraordinary items low, trailing 12 months30.92

Dividend Yield - 5 Year Average0.32

Price to sales - most recent fiscal year4.27

Dividend Yield - indicated annual dividend divided by closing price0.23

Price to Cash Flow per share - trailing 12 month44.32

Price to Free Cash Flow per Share - most recent fiscal year148.72

P/E Normalized, most recent fiscal year72.76

P/E excluding extraordinary items high, trailing 12 months97.99

P/E excluding extraordinary items, most recent fiscal year quarter90.43

Price to sales - trailing 12 month3.72

Net Debt, LFY30,879.00

Per share

Dividend Per Share - 5 year average1.08

Cash Flow per share - trailing 12 month11.95

Cash Flow per share - most recent fiscal year10.81

EPS including extraordinary items - trailing 12 month5.87

EPS including extraordinary items - most recent fiscal year6.20

EBITD per share - trailing 12 month18.46

Revenue/share - trailing 12 month142.18

EPS excluding extraordinary items - trailing 12 month5.87

EPS Basic excluding extraordinary items - most recent fiscal year6.20

EPS Basic excluding extraordinary items - trailing 12 month5.87

Book value per share - most recent fiscal year183.12

Dividend per share - most recent fiscal year1.20

Revenue/share - most recent fiscal year124.50

EPS Normalized - most recent fiscal year7.30

Book value (tangible) per share - most recent fiscal year−77.15

Dividends per share - trailing 12 month1.20

EPS excluding extraordinary items - most recent fiscal year6.20

Cash per share - most recent fiscal year3.61

Margins

Operating margin - trailing 12 month7.83

Gross Margin - 5 year average52.58

Operating margin - 1st historical fiscal year7.95

Operating Margin - 5 year average11.75

Net Profit Margin % - 1st historical fiscal year4.98

Gross Margin - 1st historical fiscal year59.27

Net Profit Margin % - trailing 12 month4.15

Net Profit Margin - 5 year average10.78

Pretax Margin - 5 year average10.91

Pretax margin - 1st historical fiscal year5.82

Pretax margin - trailing 12 month5.45

Free Operating Cash Flow/Revenue, 5 Year Average5.60

Gross Margin - trailing 12 month63.14

Growth

EPS Change %, TTM over TTM−42.69

Revenue growth rate, 5 year16.24

EPS growth rate, 5 year9.66

Revenue Change % - most recent quarter 1 year ago66.92

Growth rate% - dividend, 3 year6.27

Growth rate% - EPS, 3 year−14.03

Revenue/share (5 yr growth)15.16

Free Operating Cash Flow, 5 Year CAGR−15.70

Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR10.20

Capital Spending growth rate, 5 year38.91

Revenue Change %, TTM over TTM66.27

Growth rate% - Revenue, 3 year20.66

Book value per share growth rate, 5 year4.99

EPS Change % - most recent quarter 1 year ago−6.97

Net Profit Margin growth rate, 5 year−4.78

Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR7.85

Total Debt, 5 Year CAGR42.22

Financial strength

Net Interest coverage - most recent fiscal year4.32

Free Cash Flow - most recent fiscal year1,136.00

LT debt/equity - most recent fiscal year0.52

Quick ratio - most recent fiscal year0.81

Payout ratio - trailing 12 month20.29

Current ratio - most recent fiscal year1.88

Current EV/Free Cash Flow, LFY97.95

Total debt/total equity - most recent fiscal year0.55

Net Interest coverage - trailing 12 month3.44

Payout ratio - most recent fiscal year19.36

Returns & efficiency

Return on average equity - 5 year average5.46

Net Income/employee - trailing 12 month11,16,914.00

Revenue/employee - most recent fiscal year2,70,19,100.00

Return on investment - most recent fiscal year2.58

Return on average assets - most recent fiscal year2.35

Receivables turnover - most recent fiscal year10.55

Inventory turnover - most recent fiscal year2.48

Revenue/employee - trailing 12 month2,69,26,410.00

Return on average assets - 5 year average4.46

Net Income/employee - most recent fiscal year13,45,157.00

Asset turnover - most recent fiscal year0.47

Return on average equity - most recent fiscal year3.43

Return on investment - 5 year average5.04

Price & volume

Market Cap16,490.77

52 week Low Date2 Mar 2026

Price - 1 Day % Change2.01

Relative (S&P500) price percent change - 13 week3.96

Avg trading volume last 10 days0.25

Price - 13 week price percent change1.04

Price - 52 week price percent change12.07

Avg Trading Volume Last 3 months16.34

Price - 5 Day % Change−3.77

Price % Change Month To Date0.11

Relative (S&P500) price percent change - 04 week3.89

52 week High Date20 Jul 2026

Price - 26 week price percent change15.95

PDATE23 Sep 2026

Price - YTD price percent change16.81

Relative (S&P500) price percent change - 52 week22.97

NPRICE531.00

Relative (S&P500) price percent change - 26 week16.64

52 week Low367.55

52 week High611.85

Beta0.49

Relative (S&P500) price percent change - Year to Date33.03

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year

₹5.00

₹1.20

Dividend yield0.23%
Payout ratio19.36%
5-year average dividend₹1.08 a share
Latest dividend₹1.20 per share · 17 Jul 2026

Corporate calendar

4 Aug 2026MeetingAnnual General Meeting
4 Aug 2026BoardQuarterly Results
17 Jul 2026Dividend₹1.20 per share · 60% · Final dividend
18 May 2026BoardAudited Results & Final Dividend
3 Feb 2026BoardQuarterly Results
5 Nov 2025BoardQuarterly Results
18 Sep 2025SplitStock split — face value ₹10 → ₹2
30 Jul 2025MeetingAnnual General Meeting

Show 13 older events

30 Jul 2025BoardQuarterly Results
11 Jul 2025Dividend₹6.00 per share · 60% · Final dividend
19 May 2025BoardAudited Results, Dividend & Stock Split
4 Feb 2025BoardQuarterly Results
11 Nov 2024BoardQuarterly Results
2 Aug 2024MeetingAnnual General Meeting
19 Jul 2024Dividend₹5.00 per share · 50% · Final dividend
3 Aug 2023MeetingAnnual General Meeting
21 Jul 2023Dividend₹5.00 per share · 50% · Final dividend
29 Jul 2022MeetingAnnual General Meeting
14 Jul 2022Dividend₹5.00 per share · 50% · Final dividend
30 Jul 2021MeetingAnnual General Meeting
14 Jul 2021Dividend₹5.00 per share · 50% · Final dividend

About Zydus Wellness

Food Processing

Zydus Wellness Limited operates as an integrated consumer company. It is engaged in development, production, marketing and distribution of health and wellness products. Its portfolio spans category- food and nutrition brands: RiteBite Max Protein, Complan, Sugar Free, Sugar Free D’Lite, I’m Lite, Glucon-D and Nutralite; dietary supplement brands, including WeightWorld and MaxMedix; pet care brand Animigo; and skincare brands like Everyuth and Nycil. Glucon-D is a glucose powder brand. Glucon-D is available in regular flavors of Tangy Orange & Nimbu Pani. Complan is a nutritional drink designed for growing school children and contains 34 vital nutrients along with 100% milk protein to support growth. Nycil is a prickly heat and cooling powder brand. It offers skin care products under the brand name of Everyuth Naturals. It has four manufacturing facilities across three locations - Aligarh, Ahmedabad and Sikkim. It has 18 co-manufacturing facilities in India, UAE, and New Zealand.

Key people

Tarun AroraChief Executive Officer, Whole Time Director
Umesh Vinodray ParikhChief Financial Officer
Nandish Pradip JoshiCompany Secretary, Compliance Officer

Company facts

NSE symbolZYDUSWELL
BSE code531335
ISININE768C01028
IndustryFood Processing
IndexNIFTY 500
Market cap₹16,491 Cr
Revenue (FY26)₹3,961 Cr
Net profit (FY26)₹197 Cr

In the News

Recent headlines about Zydus Wellness — they open on Mint in a new tab.

Volume shocker stocks today: Why Innovassynth, RIR Power, Pashupati Cotspin, Zydus Wellness are soaring - Details here
Volume shocker stocks today: Stocks such as Innovassynth, RIR Power, Pashupati Cotspin, and Zydus Wellness surged in morning deals on Monday, 7 September, amid a spurt in volume.
7 Sep 2026 · 2 min read · Mint ↗
Milk-based drinks emerge as a new growth frontier
Consumer goods companies are giving milk-based drinks a protein boost as health-conscious consumers shift towards on-the-go products.
14 Aug 2026 · 4 min read · Mint ↗
What Parag Parikh Flexi Cap Fund bought and sold in June 2026: Top 10 holdings revealed
Parag Parikh Flexi Cap Fund is India's largest open-ended equity scheme with an AUM of ₹1.43 lakh crore. The fund increased its exposure to HDFC Bank, ICICI Bank and ITC in June, while trimming its holdings in Microsoft, Alphabet, Amazon and Meta Platforms.
9 Jul 2026 · 3 min read · Mint ↗
True North cashes out $2 billion for investors as PE firms step up exits
This comes on the back of exits for True North from portfolio firms like FedFina, Niva Bupa, Biocon Biologics, Infinity Fincorp Solutions, Zydus Wellness and Home First Finance.
6 Jul 2026 · 4 min read · Mint ↗
Stock market today: Gift Nifty hints positive start; eight day trading stocks to buy on Friday, 3 July
Indian stock market indices are likely to open higher, backed by positive US cues, despite Asian market losses. Benchmark indices gained significantly on Thursday, while oil prices fell, supporting investor sentiment amid geopolitical tensions in the US-Iran conflict and the Russia-Ukraine war.
3 Jul 2026 · 4 min read · Mint ↗
FMCG sector set for strong Q1, lower crude oil prices to boost margins, says Anand Rathi; Marico, HUL among top picks
The FMCG sector is expected to see healthy revenue growth in FY27, fueled by innovation and price adjustments. Anand Rathi highlights top picks like Marico and Hindustan Unilever, despite rural demand risks associated with weather conditions impacting the market.
30 Jun 2026 · 2 min read · Mint ↗
Top Gainers & Losers on June 29: Persistent Systems, Netweb Tech, Astral, MRF, Berger Paints, OLA among top losers
Indian equities continued their decline on June 29, with the Nifty 50 dropping 0.46% and the BSE Sensex falling 0.44% amid renewed Middle East tensions. While pharmaceutical and metal stocks gained, auto and technology shares suffered notable losses, reflecting mixed sectoral performance.
29 Jun 2026 · 2 min read · Mint ↗
Parag Parikh Flexi Cap doubles down on IGL, MGL; adds more ITC and bank stocks
Parag Parikh Flexi Cap Fund doubled its holdings in IGL and MGL while increasing exposure to ITC, HDFC Bank and ICICI Bank, without introducing any new stocks.
9 Jun 2026 · 3 min read · Mint ↗

Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →

Frequently Asked Questions

Zydus Wellness (NSE: ZYDUSWELL) last traded at ₹520.10 on the NSE, down 2.07% (₹10.99) on the day, as of 24 Sep 2026, 9:57 AM. On the BSE it was ₹519.00. The day's range was ₹519.00 – ₹530.85.

Zydus Wellness's 52-week high is ₹610.95 (20 Jul 2026) and its 52-week low is ₹357.55 (2 Mar 2026). At ₹520.10 the share is 14.9% below its high and 45.5% above its low.

Zydus Wellness's market capitalisation is ₹16,491 Cr (₹16,491 Cr). It is part of the NIFTY 500 index.

Zydus Wellness's P/E ratio (trailing 12 months) is 97.99. The sector average is 22.10, so investors pay 343% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹5.87.

Zydus Wellness shares are up 12.07% over the last year, up 16.81% so far this year, up 15.95% over 6 months, up 1.04% over 3 months. Over the last year the stock did 22.97% better than the market.

In FY26 (year to Mar 2026), Zydus Wellness reported revenue of ₹3,961 Cr (up 46.22% on the year before) and a net profit of ₹197 Cr. Earnings per share were ₹6.20.

Yes. Zydus Wellness's latest dividend is ₹1.20 per share (60%, final dividend), with an ex-date of 17 Jul 2026. The dividend yield is 0.23%. It has paid 6 dividends in the records shown on this page.

Of 7 analysts covering Zydus Wellness, 5 are bullish (3 strong buy, 2 buy), 2 say hold and 0 are bearish. The consensus is Buy (average rating 1.86 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.

As of Jun 2026: Promoter 69.64%, FII 3.32%, MF 18.73%, Other 8.31%. Promoter holding rose by 0.01 percentage points from Mar 2026.

Zydus Wellness's listed peers in Food Processing include Nestle India, Britannia Industries, Godrej Industries, Tata Consumer Products, Patanjali Foods. By market capitalisation it ranks #6 of 6 in this group.

Price returns

Moving averages — price is above 1 of 6

Year by year

Quarter by quarter

Balance sheet — FY26

Cash flow — FY26

Votes

How the votes changed

Valuation Is the price reasonable?

Profitability Of every ₹100 of sales, how much is kept?

Returns & efficiency How well does it use its money?

Growth Is the business getting bigger?

Financial strength Can it pay its bills and debts?

Per share What each share stands for

Valuation

Per share

Margins

Growth

Financial strength

Returns & efficiency

Price & volume

Corporate calendar

Key people

Company facts

Frequently Asked Questions

What is Zydus Wellness share price today?

What is the 52-week high and low of Zydus Wellness shares?

What is the market capitalisation of Zydus Wellness?

What is the P/E ratio of Zydus Wellness?

How has Zydus Wellness stock performed?

What were Zydus Wellness's latest annual results?

Does Zydus Wellness pay a dividend?

What do analysts recommend for Zydus Wellness shares?

What is the shareholding pattern of Zydus Wellness?

Who are Zydus Wellness's competitors?